BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 20014925)

  • 1. Should microchimerism turn into rejection prophylactics?
    Pujal JM
    Expert Rev Mol Diagn; 2010 Jan; 10(1):107-18. PubMed ID: 20014925
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mixed chimerism in SCT: conflict or peaceful coexistence?
    Liesveld JL; Rothberg PG
    Bone Marrow Transplant; 2008 Sep; 42(5):297-310. PubMed ID: 18660844
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serial chimerism analyses indicate that mixed haemopoietic chimerism influences the probability of graft rejection and disease recurrence following allogeneic stem cell transplantation (SCT) for severe aplastic anaemia (SAA): indication for routine assessment of chimerism post SCT for SAA.
    Lawler M; McCann SR; Marsh JC; Ljungman P; Hows J; Vandenberghe E; O'Riordan J; Locasciulli A; Socié G; Kelly A; Schrezenmeier H; Marin P; Tichelli A; Passweg JR; Dickenson A; Ryan J; Bacigalupo A;
    Br J Haematol; 2009 Mar; 144(6):933-45. PubMed ID: 19183198
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The possible role of microchimerism in the aetiology of autoimmune diseases].
    Jansen AG; Vossen JM; Roelen DL; ten Cate R; Bredius RG
    Ned Tijdschr Geneeskd; 2005 Jul; 149(28):1556-60. PubMed ID: 16038158
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential dynamics of donor DC and non-DC peripheral blood mononuclear cell microchimerism in lung transplantation.
    Van der Meulen J; Mifsud NA; Abud D; Paul E; Varney MD; Lewin SR; Cameron PU; Kotsimbos TC
    Clin Immunol; 2009 Nov; 133(2):179-83. PubMed ID: 19695959
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
    Petersen SL
    Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mixed allogeneic chimerism in the rat. Donor-specific transplantation tolerance without chronic rejection for primarily vascularized cardiac allografts.
    Colson YL; Zadach K; Nalesnik M; Ildstad ST
    Transplantation; 1995 Nov; 60(9):971-80. PubMed ID: 7491703
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of donor-type chimerism in lineage-specific cell populations after allogeneic myeloablative and non-myeloablative stem cell transplantation.
    Miura Y; Tanaka J; Toubai T; Tsutsumi Y; Kato N; Hirate D; Kaji M; Sugita J; Shigematsu A; Iwao N; Ota S; Masauzi N; Fukuhara T; Kasai M; Asaka M; Imamura M
    Bone Marrow Transplant; 2006 May; 37(9):837-43. PubMed ID: 16547484
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apoptotic donor leukocytes limit mixed-chimerism induced by CD40-CD154 blockade in allogeneic bone marrow transplantation.
    Li JM; Gorechlad J; Larsen CP; Waller EK
    Biol Blood Marrow Transplant; 2006 Dec; 12(12):1239-49. PubMed ID: 17162205
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of graft-versus-host disease on skin endothelial and epithelial cell chimerism in stem-cell transplant recipients.
    Willemze AJ; Bakker AC; von dem Borne PA; Bajema IM; Vossen JM
    Transplantation; 2009 Apr; 87(7):1096-101. PubMed ID: 19352133
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mixed chimerism achieved by a nonlethal conditioning regimen induces donor-specific tolerance to lung allografts.
    Li S; Salgar SK; Kurimoto Y; Yousem S; Pham SM
    J Surg Res; 2008 May; 146(2):289-97. PubMed ID: 18314139
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rapid establishment of long-term culture-initiating cells of donor origin after nonmyeloablative allogeneic hematopoietic stem-cell transplantation, and significant prognostic impact of donor T-cell chimerism on stable engraftment and progression-free survival.
    Keil F; Prinz E; Moser K; Mannhalter C; Kalhs P; Worel N; Rabitsch W; Schulenburg A; Mitterbauer M; Greinix H
    Transplantation; 2003 Jul; 76(1):230-6. PubMed ID: 12865815
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kinetics of plasma-cell chimerism after allogeneic stem cell transplantation by highly sensitive real-time PCR based on sequence polymorphism and its value to quantify minimal residual disease in patients with multiple myeloma.
    Kröger N; Zagrivnaja M; Schwartz S; Badbaran A; Zabelina T; Lioznov M; Ayuk F; Zander A; Fehse B
    Exp Hematol; 2006 May; 34(5):688-94. PubMed ID: 16647575
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chimerism and tolerance in rat recipients of intestinal allografts from ALS-treated donors with and without adjunct naïve-donor-strain bone-marrow cells.
    Nakao A; Nalesnik MA; Ishikawa T; Azhipa O; Demetris AJ; Murase N
    Transplantation; 2003 May; 75(9):1575-81. PubMed ID: 12792518
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prospective analysis between the therapy of immunosuppressive medication and allogeneic microchimerism after liver transplantation.
    Araújo MB; Leonardi LS; Leonardi MI; Boin IF; Magna LA; Donadi EA; Kraemer MH
    Transpl Immunol; 2009 Jan; 20(3):195-8. PubMed ID: 18790055
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of microchimerism in pediatric patients after living-related liver transplantation.
    Ueda M; Hundrieser J; Hisanaga M; Tanaka K; Wonigeit K; Pichlmayr R; Schlitt HJ; Yamaoka Y
    Clin Transplant; 1997 Jun; 11(3):193-200. PubMed ID: 9193841
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent progress in tolerance induction through mixed chimerism.
    Pree I; Pilat N; Wekerle T
    Int Arch Allergy Immunol; 2007; 144(3):254-66. PubMed ID: 17596699
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early complete donor hematopoietic chimerism in peripheral blood indicates the risk of extensive graft-versus-host disease.
    Balon J; Hałaburda K; Bieniaszewska M; Reichert M; Bieniaszewski L; Piekarska A; Pawłowski R; Hellmann A
    Bone Marrow Transplant; 2005 Jun; 35(11):1083-8. PubMed ID: 15821766
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation of donor leukocyte chimerism with pulmonary allograft survival after immunosuppressive drug withdrawal in a porcine model.
    Kruse B; Thissen S; Warnecke G; Avsar M; Gottlieb J; Hohlfeld JM; Karstens JH; Kaever V; Länger F; Pabst B; Ungefroren H; Haverich A; Strüber M
    Transplantation; 2009 May; 87(10):1468-77. PubMed ID: 19461483
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chimerism: a new look.
    Nikbin B; Talebian F; Mohyeddin M
    Urol J; 2007; 4(1):1-9. PubMed ID: 17514603
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.